|
시장보고서
상품코드
2055334
마우스 모델 시장 : 모델 유형별, 서비스별, 기술별, 용도별, 최종 사용자별, 지역별Mice Model Market, By Model Type, By Service, By Technology, By Application, By End User, By Geography |
||||||
마우스 모델 시장은 2026년에 20억 5,000만 달러에 달하고 2033년까지 40억 2,000만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR은 10.1%를 나타낼 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모(2026년) : | 20억 5,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 10.10% | 시장 규모 예측(2033년) : | 40억 2,000만 달러 |
세계 마우스 모델 시장은 광범위한 생의학 연구 생태계에서 중요한 부분을 차지하며, 과학적 발견과 의약품 개발에 없어서는 안 될 도구로 기능하고 있습니다. 실험용 마우스, 특히 유전자 변형 계통은 인간과의 유전적 유사성, 충분히 규명된 생물학적 시스템, 확립된 연구 프로토콜 덕분에 전임상 연구 분야의 표준으로 자리 잡고 있습니다. 이 시장에는 근친교배계, 비근친교배계, 유전자 변형 모델(GEM), 면역결핍 마우스 등 특정 인간 질환이나 병태를 재현하도록 설계된 다양한 마우스 모델이 포함됩니다.
만성 질환, 암, 신경 질환, 대사성 질환의 유병률 증가에 따라, 인간의 병태생리를 정확하게 재현할 수 있는 고도의 동물 모델에 대한 수요가 높아지고 있습니다. 학술 기관, 제약 회사, 생명공학 기업 및 수탁 연구 기관은 신약 개발, 독성 시험, 유효성 시험 및 맞춤형 의료 연구에서 이러한 모델에 크게 의존하고 있습니다. 시장의 성장은 CRISPR-Cas9과 같은 유전공학 기술의 발전에 힘입어 더욱 가속화되고 있습니다. 이러한 기술을 통해 보다 정밀하고 질환 특이적인 마우스 모델을 개발할 수 있게 되며, 이를 통해 연구 성과가 향상되고 실험실에서의 연구 결과를 임상 적용으로 신속하게 전환할 수 있게 됩니다.
시장 역학
세계 마우스 모델 시장의 성장은 제약 및 생명공학 분야 전반의 견실한 확장을 종합적으로 뒷받침하는 몇 가지 주요 요인에 의해 주도되고 있습니다. 주요 원인은 신약 개발 및 연구 활동의 급격한 확대에 있으며, 제약 기업들은 인간 대상 임상시험에 착수하기 전에 치료 효과와 안전성 프로파일을 평가하기 위해 고도로 정교한 마우스 모델에 대한 의존도를 높이고 있습니다. 암, 당뇨병, 심혈관 질환, 신경 질환 등 만성 질환의 유병률 증가에 따라, 인간의 병태생리를 정확하게 재현할 수 있는 질환 특이적 마우스 모델의 개발이 필요해지고 있으며, 이것이 시장 수요를 견인하고 있습니다.
또한, 유전공학, 특히 CRISPR-Cas9 및 기타 유전자 편집 기술의 발전은 유전자 변형 마우스 모델의 개발에 혁명을 일으켰으며, 연구자들이 더욱 정밀하고 표적화된 실험 시스템을 개발할 수 있게 해주었습니다. 그러나 시장은 성장 궤도를 가로막는 중대한 제약에 직면해 있습니다. 윤리적 고려 사항 및 규정 준수 요건을 포함한 동물 실험을 규제하는 엄격한 체계는 시장 확대의 걸림돌이 되고 있으며, 연구 기관의 운영 비용을 증가시키고 있습니다. 체외 모델, 장기-온-칩 기술, 컴퓨터 모델링 등 대체 시험법에 대한 관심이 높아지고 있는 것은 기존의 동물 실험을 기반으로 한 연구 패러다임에 잠재적인 위협이 되고 있습니다. 게다가 특수한 마우스 계통의 번식, 유지, 사육에 따르는 높은 비용에 더해, 전문 시설과 훈련을 받은 인력의 필요성이 소규모 연구 기관의 진입 장벽이 되고 있습니다.
이러한 과제가 있음에도 불구하고, 맞춤형 의료 접근법의 도입이 확대됨에 따라 큰 기회가 생겨나고 있습니다. 맞춤형 의료 접근법에서는 환자에게 맞는 치료법을 개발하기 위해 환자 특이적인 마우스 모델이 필요합니다. 전문적인 마우스 모델 서비스를 제공하는 수탁 연구 기관(CRO)의 확대는 특히 연구 인프라가 급속히 발전하고 있는 신흥 시장에서 시장 성장을 위한 유망한 기회를 제공합니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 세계 마우스 모델 시장의 주요 기업 프로파일을 작성하였습니다. 구체적으로는 기업의 주요 정보, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략입니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계의 마우스 모델 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 마우스 모델 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적 및 전제 조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 마우스 모델 시장 : 모델 유형별(2021-2033년)
제5장 세계의 마우스 모델 시장 : 서비스별(2021-2033년)
제6장 세계의 마우스 모델 시장 : 기술별(2021-2033년)
제7장 세계의 마우스 모델 시장 : 용도별(2021-2033년)
제8장 세계의 마우스 모델 시장 : 최종 사용자별(2021-2033년)
제9장 세계의 마우스 모델 시장 : 지역별(2021-2033년)
제10장 경쟁 구도
제11장 애널리스트의 제안
제12장 참고 문헌 및 조사 방법
KTH 26.06.19Mice Model Market is estimated to be valued at USD 2.05 Bn in 2026 and is expected to reach USD 4.02 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2.05 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 10.10% | 2033 Value Projection: | USD 4.02 Bn |
The global mice model market represents a critical segment within the broader biomedical research ecosystem, serving as an indispensable tool for scientific discovery and pharmaceutical development. Laboratory mice, particularly genetically modified strains, have become the gold standard for preclinical research due to their genetic similarity to humans, well-characterized biological systems, and established research protocols. This market encompasses various mouse models including inbred strains, outbred stocks, Genetically Engineered Models (GEMs), and immunodeficient mice, each designed to replicate specific human diseases and conditions.
The increasing prevalence of chronic diseases, cancer, neurological disorders, and metabolic conditions has intensified the demand for sophisticated animal models that can accurately mimic human pathophysiology. Academic institutions, pharmaceutical companies, biotechnology firms, and contract research organizations heavily rely on these models for drug discovery, toxicology studies, efficacy testing, and personalized medicine research. The market's growth is further propelled by technological advancements in genetic engineering techniques such as CRISPR-Cas9, which enable the development of more precise and disease-specific mouse models, thereby enhancing research outcomes and accelerating the translation of laboratory findings into clinical applications.
Market Dynamics
The global mice model market growth is driven by several compelling factors that collectively fuel its robust expansion across the pharmaceutical and biotechnology sectors. The primary driver stems from the exponential growth in drug discovery and development activities, where pharmaceutical companies increasingly rely on sophisticated mouse models to evaluate therapeutic efficacy and safety profiles before advancing to human trials. The rising prevalence of chronic diseases, including cancer, diabetes, cardiovascular disorders, and neurological conditions, necessitates the development of disease-specific mouse models that can accurately replicate human pathophysiology, thereby driving market demand.
Additionally, technological advancements in genetic engineering, particularly CRISPR-Cas9 and other gene-editing technologies, have revolutionized the creation of genetically modified mouse models, enabling researchers to develop more precise and targeted experimental systems. However, the market faces significant restraints that challenge its growth trajectory. Stringent regulatory frameworks governing animal research, including ethical considerations and compliance requirements, create barriers for market expansion and increase operational costs for research institutions. The growing emphasis on alternative testing methods, such as in-vitro models, organ-on-chip technologies, and computational modeling, poses a potential threat to traditional animal-based research paradigms. Furthermore, the high costs associated with breeding, maintaining, and housing specialized mouse strains, coupled with the need for specialized facilities and trained personnel, limit accessibility for smaller research organizations.
Despite these challenges, substantial opportunities emerge from the increasing adoption of personalized medicine approaches, which require patient-specific mouse models for tailored therapeutic development. The expansion of contract research organizations offering specialized mouse model services presents lucrative opportunities for market growth, particularly in emerging markets where research infrastructure is rapidly developing.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global mice model market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Charles River Laboratories, The Jackson Laboratory, Inotiv, genOway, Taconic Biosciences, Janvier Labs, Crown Bioscience, Cyagen Biosciences, GemPharmatech, Shanghai Model Organisms Center (SMOC), Biocytogen, Ozgene Pty Ltd, Trans Genic Inc., Harbour BioMed, and JSR Life Sciences
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global mice model market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global mice model market
Market Segmentation
- Model Type Insights (Revenue, USD Bn, 2021 - 2033)
- Genetically Engineered Mice (GEM)
- Knockout Mice
- Knock-in Mice
- Conditional Mutant Mice
- Inbred Mice
- Outbred Mice
- Hybrid/Congenic Mice
- Spontaneous Mutant Mice
- Service Insights (Revenue, USD Bn, 2021 - 2033)
- Breeding Services
- Cryopreservation, Rederivation, and Resequencing Services
- Genetic Testing and Characterization Services
- Model In-vivo and In-vitro Testing Services
- Custom Model Development Services
- Technology Insights (Revenue, USD Bn, 2021 - 2033)
- CRISPR/Cas9
- Embryonic Stem Cell (ESC) Technology
- Nuclear Transfer Technology
- Microinjection Technology
- Others (e.g., TALENs, ZFNs)
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Oncology Research
- Immunology and Inflammation Studies
- Diabetes Research
- Cardiovascular Research
- Neurological Disease Research
- Rare Disease Research
- Toxicology and Safety Assessment
- Others (e.g., Metabolic Disorders, Infectious Diseases)
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutions
- Contract Research Organizations (CROs)
- Government and Nonprofit Organizations
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Charles River Laboratories
- The Jackson Laboratory
- Inotiv
- genOway
- Taconic Biosciences, Inc.
- Janvier Labs
- Crown Bioscience
- Cyagen
- GemPharmatech
- Shanghai Model Organisms Center, Inc.
- Biocytogen
- Ozgene Pty Ltd
- Trans Genic Inc.
- Harbour BioMed
- JSR Life Sciences, LLC
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Mice Model Market, By Model Type
- Global Mice Model Market, By Service
- Global Mice Model Market, By Technology
- Global Mice Model Market, By Application
- Global Mice Model Market, By End User
- Global Mice Model Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Mice Model Market, By Model Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Genetically Engineered Mice (GEM)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Knockout Mice
- Knock-in Mice
- Conditional Mutant Mice
- Inbred Mice
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Outbred Mice
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Hybrid/Congenic Mice
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Spontaneous Mutant Mice
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Mice Model Market, By Service, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Breeding Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cryopreservation, Rederivation, and Resequencing Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Genetic Testing and Characterization Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Model In-vivo and In-vitro Testing Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Custom Model Development Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Mice Model Market, By Technology, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- CRISPR/Cas9
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Embryonic Stem Cell (ESC) Technology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Nuclear Transfer Technology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Microinjection Technology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (e.g., TALENs, ZFNs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Mice Model Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oncology Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Immunology and Inflammation Studies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diabetes Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cardiovascular Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Neurological Disease Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Rare Disease Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Toxicology and Safety Assessment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (e.g., Metabolic Disorders, Infectious Diseases)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Mice Model Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Academic and Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Government and Nonprofit Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Mice Model Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Model Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Model Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Model Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Model Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Model Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Model Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Service, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- The Jackson Laboratory
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Inotiv
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- genOway
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Taconic Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Janvier Labs
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Crown Bioscience
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cyagen Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GemPharmatech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Shanghai Model Organisms Center (SMOC)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biocytogen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ozgene Pty Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Trans Genic Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Harbour BioMed
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- JSR Life Sciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
